Voorbeelden van het gebruik van This subgroup in het Engels en hun vertalingen in het Nederlands
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Financial
-
Computer
-
Ecclesiastic
-
Official/political
-
Programming
See more ads in this subgroup.
This subgroup covers f. paniculata,
Therefore all permissions need not be defined again for this subgroup.
It is for this subgroup of patients that a HIPEC may be an option.
According to professionals, the hybrid is considered the most fruitful among this subgroup.
This subgroup of comets is known as Subgroup II.
Limited data are available in this subgroup of patients see sections 4.2 and 5.1.
This subgroup conducted two types of discussions during 1993.
Patients with missing cirrhosis status were excluded from this subgroup analysis.
Results in this subgroup were consistent with those in the overall population.
other calcium antagonists of this subgroup);
In this subgroup, there was a 92%(89/97) sustained virological response rate.
The safety and efficacy of eluxadoline in this subgroup of IBS-D patients has not been established.
In this subgroup, there was a 56%(463/823) sustained virological response rate.
Moreover, the safety profile of clopidogrel in this subgroup of patients did not raise any particular concern.
This subgroup of patients is considered to constitute the core efficacy population.
severe exacerbations were observed in this subgroup as compared with the overall population.
The analysis from this subgroup of patients yielded a median progression-free survival of 15.6 months.
establish the safety and efficacy in patients≥ 75 years due to limited data in this subgroup.
In this subgroup all-cause mortality was significantly reduced with valsartan compared to placebo by.
Adverse reactions appeared to be more frequent in this subgroup with organ impairment than in other observed infants without organ impairment.
This subgroup had a high degree of bad prognostic markers,
shorter duration of TYSABRI exposure for this subgroup of patients should be considered when interpreting these data.
Results in this subgroup were numerically consistent with those in the overall population
The treatment difference in this subgroup was comparable to that observed in patients with ppFEV1≥40.
This subgroup of men with chronic acne is either hyperresponsive to LH,
The safety results in this subgroup of patients undergoing PCI were comparable to the overall safety results.
This subgroup is studying on one hand the interactions between parasites
The high sustained response rate in this subgroup of patients was identified in an interim analysis(n=49)
In this subgroup, after an initial 10 mg daily dose,